中

ADR Reporting

EvoMab™ Platform

Ultra-Long-Acting Multispecific Antibody

Gensci Pharmaceutical: Ultra-long-lasting Multi-specific Antibody Technology Platform



Macromolecular EvoMab™ Technology Platform —Long-lasting, Stable, Cost-effective

Provide stable blood drug concentrations, enhance therapeutic efficacy and safety, and significantly improve patients quality of life and treatment adherence.


Back